Elana Swartzman
Papers
1
Total Citations
67
H-Index
1
About
Elana Swartzman is a pioneering figure in the development of high-throughput screening (HTS) technologies, with a particular focus on homogeneous, miniaturized assay systems. Her most-cited work, "Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology" (1999), has garnered 67 citations and stands as a foundational contribution to the field. In this seminal paper, Swartzman introduced innovative fluorometric microvolume assay technology, enabling sensitive, rapid, and cost-effective screening of cellular and bead-based interactions. This work significantly advanced drug discovery by reducing reagent consumption and increasing assay throughput, directly impacting the efficiency of pharmaceutical and biomedical research. Swartzman’s contributions are notable for bridging the gap between traditional plate-based assays and modern miniaturized platforms, influencing subsequent developments in HTS automation and fluorescence-based detection. Her research remains highly cited among scientists developing homogeneous assays for cell signaling, receptor binding, and compound library screening. Through her technical innovations, Swartzman has helped shape the landscape of early-stage drug discovery, making her a respected authority in assay miniaturization and high-throughput methodologies.
Research Focus
Key Achievements
Top Papers
- 1